Enveric Biosciences (ENVB) FCF Margin (2014 - 2020)
Enveric Biosciences (ENVB) reported FCF Margin of -4.71% for Q3 2020, down 0.50 percentage points from the prior quarter.
Powered by 
Analysis
Enveric Biosciences (ENVB) FCF Margin (2014 - 2020) Analysis & Trends
Over the twelve months ended Sep 30, 2020, Enveric Biosciences' FCF Margin came in at -2.59%, up 3.46 percentage points year-over-year; for FY2019, it came in at -1.83%, up 4.12 percentage points from FY2018.
- FCF Margin has a four-year change of +17.43 percentage points (FY2015 to FY2019).
- By year, FCF Margin came in at -5.95% in FY2018 (-0.30 pp), -5.65% in FY2017 (+1.91 pp), -7.56% in FY2016 (+11.70 pp) and -19.26% in FY2015.
- Five-year quarterly FCF Margin spans a low of -24.20% in Q4 2016 and a high of 8.49% in Q4 2019.
- Year over year, FCF Margin gained in two of the last six quarters, with an average year-over-year change of +0.89 percentage points.
- The high point for year-over-year FCF Margin in five years was Q3 2016 (a gain of 78.36 percentage points); the low point was Q4 2016 (a drop of 29.72 percentage points).
- Per Business Quant data, the three quarters before Q3 2020 came in at -4.21% (Q2 2020), -9.76% (Q1 2020) and 8.49% (Q4 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | Enveric Biosciences | 5.86 Mn | -15.78 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | -4.71% |
| Jun 30, 2020 | -4.21% |
| Mar 31, 2020 | -9.76% |
| Dec 31, 2019 | 8.49% |
| Jun 30, 2019 | -4.59% |
| Mar 31, 2019 | -9.32% |
| Dec 31, 2018 | -9.58% |
| Sep 30, 2018 | -12.11% |
| Jun 30, 2018 | 1.50% |
| Mar 31, 2018 | -4.15% |
| Dec 31, 2017 | -8.19% |
| Sep 30, 2017 | -0.79% |
| Jun 30, 2017 | -7.01% |
| Mar 31, 2017 | -6.87% |
| Dec 31, 2016 | -24.20% |
| Sep 30, 2016 | 5.57% |
| Jun 30, 2016 | -4.76% |
| Mar 31, 2016 | 0.31% |
| Dec 31, 2015 | 5.52% |
| Sep 30, 2015 | -72.78% |
API Access
Enveric Biosciences FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=ENVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();